Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection

Journal of Medical Virology

Volumn 81, Issue 3, 2009, Pages 519-528

  Arévalo, Maria T ^a   Simpson Haidaris, Patricia J ^a   Kou, Zhihua ^a   Schlesinger, Jacob J ^a   Jin, Xia ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

ADE; Dengue; HUVEC

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIA; VIRUS RNA;

APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MACROPHAGE; MOLECULAR CLONING; MONOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VIRUS REPLICATION; ANTIBODY DEPENDENT ENHANCEMENT; BIOSYNTHESIS; PHYSIOLOGY; VIROLOGY; VIRUS CULTURE;

DENGUE VIRUS;

ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; ENDOTHELIAL CELLS; HUMANS; PLAQUE ASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRUS REPLICATION;

EID: 60049084641     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21408     Document Type: Article

References (52)

1. Alberto MF, Bermejo EI, Lazzari MA. 2000. Receptor expression for IgG constant fraction in human umbilical vein endothelial cells. Thromb Res 97:505-511.
2. Andrews BS, Theofilopoulos AN, Peters CJ, Loskutoff DJ, Brandt WE, Dixon FJ. 1978. Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect Immun 20:776-781.
3. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161:6338-6346.
4. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Yenchitsomanus P, Mongkolsapaya J, Kasinrerk W, Sittisombut N, Husmann M, Blettner M, Vasanawathana S, Bhakdi S, Malasit P. 2006. Vascular leakage in severe dengue virus infections: A potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193:1078-1088.
5. Blackley SD, Kou Z, Chen H, Quinn M, Rose RC, Schlesinger JJ, Coppage M, Jin X. 2007. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol 81:13325-13334.
6. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier MV, Ennis FA, Rothman A. 2002. Increase production of interleukin-8 primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 76:5588-5597.
7. Carr JM, Hocking H, Bunting K, Wright PJ, Davidson A, Gamble J, Burrell CJ, Li P. 2003. Supernatants from dengue virus type-2 infected macrophage induce permeability changes in endothelial cell monolayers. J Med Virol 69:521-528.
8. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA. 2007. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 81:5518-5526.
9. Cines DB, Lyss AP, Bina M, Corkey R, Kefalides NA, Friedman HM. 1982. Fc and C3 receptors induced by HSV on cultured human endothelial cells. J Clin Invest 69:123-128.
10. Clyde K, Kyle JL, Harris E. 2006. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80:11418-11431.
11. Devaraj S, Clos T, Jialal I. 2005. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Bio 25:1359-1363.
12. Dewi BE, Takasaki T, Kurane I. 2004. In vitro assessment of human endothelial cell permeability: Effects of inflammatory cytokines and dengue virus infection. J Virol Methods 121:171-180.
13. Dewi BE, Takasaki T, Kurane I. 2008. Peripheral blood mononuclear cells increase the permeability of dengue virus-infected endothelial cells in association with downregulation of vascular endothelial cadherin. J Gen Virol 89:642-652.
14. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74:7814-7823.
15. Edelman R. 2005. Dengue and dengue vaccines. J Infect Dis 191:650-653.
16. Edelman R. 2007. Dengue vaccines approach the finish line. CID 45:S56-S60.
17. Favaloro EJ. 1993. Differential expression of surface antigens on activated endothelium. Immunol Cell Biol 71:571-581.
18. Friedman HM. 1989. Infection of endothelial cells by human viruses. Rev Infect Dis 11:S700-S704.
19. Groger M, Sarmay G, Fiebiger E, Wolff K, Petzelbauer P. 1996. Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro. J Immunol 156:1549-1556.
20. Halstead SB. 1980. Immunological parameters of togavirus disease syndromes. In: Schlesinger RW, editor. The togaviruses - Biology, structure, replication. New York: Academic Press. pp 107-173.
21. Halstead S. 1988. Pathogenesis of dengue: Challenges to molecular biology. Science 239:476-481.
22. Halstead S. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: A pathogenetic cascade. Rev Infect Dis 11:S830-S839.
23. Halstead S, Simasthien P. 1970. Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J Biol Med 42:276-292.
24. Huang Y, Lei H, Liu H, Lin Y, Liu C, Yeh T. 2000. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63:71-75.
25. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. 2004. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189:1411-1418.
26. Kiessling F, Kartenbeck J, Haller C. 1999. Cell-cell contacts in the human cell line ECV304 exhibit both endothelial and epithelial characteristics. Cell Tissue Res 297:131-140.
27. Kinney RM, Butrapet S, Chang G-JJ, Tsuchiya KR, Roehrig JT, Bhamaraprvati N, Gubler DJ. 1997. Construction of infectious cDNA clones for dengue 2 virus: Strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230:300-308.
28. Kliks S. 1990. Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Res Hum Retroviruses 6:993-998.
29. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38:411-419.
30. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40:444-451.
31. Klimstra W, Ryman K, Johnston RE. 1998. Adaptation of sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol 72:7357-7366.
32. Kontny U, Kurane I, Ennis FA. 1988. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 62:3298-3933.
33. Kou Z, Quinn M, Chen H, Rodrigo WW, Rose RC, Schlesinger JJ, Jin X. 2008. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol 80:134-146.
34. Krishnamurti C, Peat R, Cutting M, Rothwell S. 2002. Platelet Adhesion to Dengue-2 Virus-Infected Endothelial Cells. Am J Trop Med Hyg 66:435-441.
35. Lee Y-R, Liu M-T, Lei H-Y, Liu C-C, Wu J-M, Tung Y-C, Lin Y-S, Yeh T-M, Chen S-H, Liu H-S. 2006. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions on vascular endothelium cells. J Gen Virol 87:3623-3630.
36. Leitmeyer K, Vaughn D, Watts D, Salas R, Villalobos I, de Chacon, Ramos C, Rico-Hesse R. 1999. Dengue virus structural differences that correlate with pathogenesis. J Virol 73:4738-4747.
37. Liang Y-J, Shyu K-G, Wang B-W, Lai L-P. 2006. C-reactive protein activates the nuclear factor-κB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. J Mol Cell Cardiol 40:412-420.
38. Liew K, Chow V. 2004. Differential display RT-PCR analysis of ECV304 endothelial-like cells infected with dengue virus type 2 reveals messenge RNA expression profiles of multiple human genes involved in known and novel roles. J Med Virol 2004:597-609.
39. Liew K, Chow V. 2006. Microarray and real-time RT-PCR analyses of a novel set of differentially expressed human genes in ECV304 endothelial-like cells infected with dengue virus type 2. J Virol Methods 131:47-57.
40. Limonta D, Cap V, Torres G, Perez AB, Guzman MG. 2007. Apoptosis in tissues from fatal dengue shock syndrome. J Clin Virol 40:50-54.
41. Littaua R, Kurane I, Ennis FA. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144:3183-3186.
42. MacCormac LP, Grundy JE. 1996. Human cytomegalovirus induces Fc gamma receptor (Fc gammaR) in endothelial cells and fibroblasts that is distinct from the human cellular Fc GammaRs. J Infect Dis 174:1151-1161.
43. Pang T, Cardosa MJ, Guzman MG. 2007. Of cascades and perfect storms: The immunopathogenesis of dengue haemorrhagic fever-dengue shock sydnrome (DHF/DSS). Immunol Cell Biol 85:43-45.
44. Peyrefitte C, Pastorino B, Grau G, Lou J, Tolou H, Couissinier-Paris P. 2006. Dengue virus infection of human microvascular endothelial cells from different vascular beds promotes both common and specific functional changes. J Med Virol 78:229-242.
45. Rodrigo WWSI, Jin X, Blackley SD, Rose RC, Schlesinger JJ. 2006. Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human FcγRIA (CD64) or FcγRIIA (CD32). J Virol 80:10128-10138.
46. Sedmak DD, Davis DH, Singh U, van de Winkel JGJ, Anderson CL. 1991. Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans. Am J Pathol 138:175-181.
47. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. 2004. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 85:1801-1813.
48. Vaughn DW, Green S, Kalayanarooy S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raegsakulrach B, Rothman AL, Nisalak A. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181:2-9.
49. Wagner D, Olmsted J, Marder V. 1982. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 95:355-360.
50. Warke RV, Xhaja K, Martin KJ, Fournier MF, Shaw SK, Brizuela N, de Bosch N, Lapointe D, Ennis FA, Rothman AL, Bosch I. 2003. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 77:11822-11832.
51. Welsh R, Rothman AL. 2003. Dengue immune response: Low affinity, high febrility. Nat Med 9:820-822.
52. Whitehead SS, Blaney JE, Durbin AP, Murphy BR. 2007. Prospects for a dengue virus vaccine. Nature 5:518-528.